SurgePays, Inc. to Post Q1 2024 Earnings of $0.27 Per Share, Sidoti Csr Forecasts (NASDAQ:SURG)

SurgePays, Inc. (NASDAQ:SURGFree Report) – Analysts at Sidoti Csr issued their Q1 2024 earnings estimates for SurgePays in a research report issued to clients and investors on Tuesday, April 23rd. Sidoti Csr analyst A. Soderstrom expects that the medical equipment provider will earn $0.27 per share for the quarter. Sidoti Csr also issued estimates for SurgePays’ Q2 2024 earnings at $0.00 EPS, Q3 2024 earnings at $0.05 EPS, Q4 2024 earnings at $0.09 EPS, FY2024 earnings at $0.42 EPS, Q1 2025 earnings at $0.13 EPS, Q2 2025 earnings at $0.14 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.17 EPS and FY2025 earnings at $0.61 EPS.

SurgePays (NASDAQ:SURGGet Free Report) last posted its earnings results on Tuesday, March 12th. The medical equipment provider reported $0.19 EPS for the quarter. The firm had revenue of $32.32 million for the quarter. SurgePays had a net margin of 15.03% and a return on equity of 104.66%.

SURG has been the subject of a number of other reports. Ascendiant Capital Markets decreased their price target on shares of SurgePays from $11.50 to $10.00 and set a “buy” rating for the company in a report on Monday, April 1st. Maxim Group cut shares of SurgePays from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th.

View Our Latest Stock Analysis on SURG

SurgePays Trading Down 5.3 %

SurgePays stock opened at $3.33 on Thursday. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.63 and a quick ratio of 1.91. The company has a market capitalization of $64.24 million, a price-to-earnings ratio of 2.40 and a beta of 1.08. SurgePays has a one year low of $3.28 and a one year high of $9.23. The company’s fifty day moving average price is $5.24 and its two-hundred day moving average price is $5.78.

Institutional Investors Weigh In On SurgePays

Several hedge funds have recently made changes to their positions in SURG. Bailard Inc. lifted its stake in shares of SurgePays by 340.9% in the third quarter. Bailard Inc. now owns 59,075 shares of the medical equipment provider’s stock valued at $276,000 after buying an additional 45,675 shares during the period. James Investment Research Inc. bought a new stake in shares of SurgePays in the third quarter valued at about $47,000. FNY Investment Advisers LLC bought a new stake in shares of SurgePays in the fourth quarter valued at about $95,000. Victory Capital Management Inc. acquired a new position in SurgePays in the fourth quarter worth about $106,000. Finally, Jump Financial LLC raised its position in SurgePays by 44.7% in the fourth quarter. Jump Financial LLC now owns 16,500 shares of the medical equipment provider’s stock worth $106,000 after purchasing an additional 5,100 shares in the last quarter. Institutional investors own 6.94% of the company’s stock.

About SurgePays

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

See Also

Earnings History and Estimates for SurgePays (NASDAQ:SURG)

Receive News & Ratings for SurgePays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurgePays and related companies with MarketBeat.com's FREE daily email newsletter.